Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chopra

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|November 11, 1991
The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cellsH Chopra, J Timar, Y Q Chen, et al.
Leukemia & Lymphoma|April 28, 2000
Telomerase activity in preleukemia and acute myelogenous leukemiaB Li, J Yang, C Andrews, et al.
American Journal of Ophthalmology|July 15, 1992
Apraclonidine and argon laser trabeculoplastyP C Holmwood, R D Chase, T Krupin, et al.
Clinical & Experimental Metastasis|March 1, 1992
Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction?H Chopra, J Timar, X Rong, et al.
International Journal of Hematology|May 1, 1999
The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrowsS Mundle, P Venugopal, V Shetty, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 29, 2000
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertensionW C Stewart, E D Sharpe, D G Day, et al.
Leukemia Research|August 8, 2001
Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapyE Devemy, B Li, M Tao, et al.
Cancer Research|November 15, 1995
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasJ R Graff, J G Herman, R G Lapidus, et al.
Cancer Research|July 1, 1988
Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregationH Chopra, J S Hatfield, Y S Chang, et al.
Mucosal Immunology|August 16, 2013
The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodesS Cording, B Wahl, D Kulkarni, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|November 11, 1991
The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cellsH Chopra, J Timar, Y Q Chen, et al.
Leukemia & Lymphoma|April 28, 2000
Telomerase activity in preleukemia and acute myelogenous leukemiaB Li, J Yang, C Andrews, et al.
American Journal of Ophthalmology|July 15, 1992
Apraclonidine and argon laser trabeculoplastyP C Holmwood, R D Chase, T Krupin, et al.
Clinical & Experimental Metastasis|March 1, 1992
Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction?H Chopra, J Timar, X Rong, et al.
International Journal of Hematology|May 1, 1999
The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrowsS Mundle, P Venugopal, V Shetty, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 29, 2000
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertensionW C Stewart, E D Sharpe, D G Day, et al.
Leukemia Research|August 8, 2001
Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapyE Devemy, B Li, M Tao, et al.
Cancer Research|November 15, 1995
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasJ R Graff, J G Herman, R G Lapidus, et al.
Cancer Research|July 1, 1988
Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregationH Chopra, J S Hatfield, Y S Chang, et al.
Mucosal Immunology|August 16, 2013
The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodesS Cording, B Wahl, D Kulkarni, et al.
Pageof 6